Search
Saul Ewing LLP, a full-service national law firm, is proud to announce that Intellectual Property Practice Co-Chair Bill Baton was selected by NJBIZ as a 2025 Leaders in Law honoree. The awards honor legal professionals whose dedication to their occupation and to their communities is outstanding...
Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial. Join Jason A. Lief of Windels Marx and William C. Baton of Saul Ewing LLP in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the...
Saul Ewing LLP will be a Bronze Sponsor at the 7th Annual LF Dealmakers Forum in NYC, September 17-19, 2024. Based on the success of IP Dealmakers – and our experience examining complex markets and bringing together influential groups in the converging fields of legal and finance – we launched the...
Saul Ewing LLP is proud to announce that Charles M. Lizza, Vice Chair of the firm’s Litigation Department, was named to the NJBIZ 2024 Law Power 50 list. This is the sixth year in a row that Mr. Lizza has been included on this list of the state's top lawyers. Professionals are selected for the list...
In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a monthly series discussing emerging industry developments and common issues that cannabis businesses face today. Interested in the full series? Learn more about additional dates and topics. For questions, please contact Mary...
Lawyers Only: Making Litigation Funding Better What are the best practices for firms to seek working capital? How do firms recommend funders for their clients? How are law firms contemplating using funding or investment for cases after filing? How does one navigating the ethical, privilege...
Litigation Risk Insurance; New Coverages; Risk Solutions; and Nuclear Claims? Litigation risk insurance, which for the most part, insures against adverse judgments or assists in preserving judgments, has become popular in the last few years. What is litigation risk insurance? How is it underwritten...
Breaking (free from) the Bank: Cannabis Litigation Finance This panel provides an overview of litigation finance, explores unique aspects of cannabis litigation that make cannabis litigation finance necessary, and provides resources for cannabis attorneys and their clients as they explore litigation...
Panel 4: The Connections Between Insurance and Litigation Funding Join Partner Brian Michalek and the University of Chicago Center on Law and Finance , in sponsorship with Burford Capital and Alliant, at the 2023 Chicago Conference on Litigation Finance. This conference will explore the policy...
Saul Ewing’s Casey Grabenstein and Andrew Schwerin write that courts are divided on whether plaintiff bias justifies discovery about litigation funding. They argue litigation funding wouldn’t often create a conflict of interest for a plaintiff.
Contingent Liability Insurance Demystified Partner Brian Michalek will speak on a panel during the 2023 Transaction Solutions Symposium. More information to come.
Strategically Positioned to Navigate Distress, Drive Opportunity Saul Ewing’s Distressed Transactions practice provides comprehensive, interdisciplinary solutions for clients such as businesses, investors or stakeholders navigating market distress and economic uncertainty. Our team performs due...
David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...
Jeffrey Letwin counsels businesses in complex matters including corporate finance, mergers and acquisitions, franchising, real estate finance and development. He also advises enterprises in the interface between governmental and economic development agencies and devises financing strategies...
Eric Orlinsky concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity securities, mergers and acquisitions, purchases and sales of businesses. Eric also provides general...
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...